All Companies
BMY
Bristol-Myers Squibb Co.Pharmaceutical Preparations
$63.06updated Sep 19, 2026
Congressional trading profile for Bristol-Myers Squibb Co. (BMY), covering 17 disclosed transactions by 10 lawmakers.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Total Trades
17
Politicians Trading
10
Last Traded
Jun 16, 2026
Price history
Congressional Trades
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Ro KhannaD | Jul 6, 2026 | Jun 16, 2026 | Sell | $1,001 - $15,000 | +12.77% |
| Mike KellyR | Jun 11, 2026 | May 7, 2026 | Sell | $15,001 - $50,000 | +12.11% |
| Julie JohnsonD | Jan 15, 2026 | Dec 18, 2025 | Sell | $1,001 - $15,000 | +18.24% |
| Julia LetlowR | Jan 13, 2026 | Apr 28, 2025 | Sell | $1,001 - $15,000 | +30.13% |
| Julie JohnsonD | Dec 11, 2025 | Nov 13, 2025 | Sell | $1,001 - $15,000 | +29.67% |
| Gilbert Ray Cisneros, Jr.D | Nov 18, 2025 | Oct 9, 2025 | Sell | $1,001 - $15,000 | +41.14% |
| Julie JohnsonD | Sep 11, 2025 | Aug 14, 2025 | Sell | $1,001 - $15,000 | +31.90% |
| Virginia FoxxR | Jul 3, 2025 | Jun 24, 2025 | Sell | $1,001 - $15,000 | +34.08% |
| Jefferson ShreveR | Jun 22, 2025 | May 12, 2025 | Sell | $15,001 - $50,000 | +30.88% |
| Tommy TubervilleR | May 15, 2025 | Apr 15, 2025 | Sell | $1,001 - $15,000 | +26.12% |
| Julie JohnsonD | May 14, 2025 | Apr 1, 2025 | Sell | $1,001 - $15,000 | +5.89% |
| Greg LandsmanD | Apr 8, 2025 | Mar 27, 2025 | Sell | $1,001 - $15,000 | +7.06% |